Total Bilirubin Levels in Nonalcoholic Fatty Liver Disease and All- cause and Cause-specific Mortality in US Adults
Journal of Gastrointestinal and Liver Diseases · 28.09.2023 · 32 (3) · 323-331
DOI: 10.15403/jgld-4732 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastrointestinal and Liver Diseases, online erschienen am 28.09.2023. Verfasst von Kasey Moss und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, McMaster University, Hamilton, ON, Canada. . kasey.moss@medportal.ca. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Aims: Nonalcoholic Fatty Liver Disease (NAFLD) is a chronic progressive illness with a spectrum of disease severity from steatosis to end-stage liver disease. Emerging evidence suggests total serum bilirubin levels are inversely related to the prevalence of metabolic syndrome including NAFLD. We investigated the effects of bilirubin on all-cause and cause-specific mortality stratified by NAFLD status.
Methods
We used the third National Health and Nutrition Examination Survey Cohort (1988-1994) and linked mortality dataset through 2019. Cox-regression models were constructed to assess the association between bilirubin levels categorized by quartile with all-cause and cause-specific mortality.
Results
During the median follow-up of 324 months (n=11,078), higher bilirubin levels were associated with a reduction in risk of all-cause mortality in the multivariate model (hazard ratio [HR]: 0.83, 95% confidence interval [CI]: 0.71-0.97 for quarter 4 [highest bilirubin levels] vs. quarter 1 [lowest bilirubin levels], p for trend=0.033). Higher bilirubin levels were associated with a lower risk for all-cause mortality in individuals with NAFLD (HR; 0.68, 95% CI: 0.55-0.86 for quarter 4, p for trend=0.010); however, this protective association with higher bilirubin levels was not noted in those without NAFLD. Higher bilirubin levels were associated with a lower risk for cardiovascular and cancer-related mortality in individuals with NAFLD.
Conclusions
In this large nationally representative sample of American adults, higher bilirubin levels in NAFLD were associated with a lower risk of all-cause mortality, which may be derived from a lower risk of cardiovascular/cancer-related mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, McMaster University, Hamilton, ON, Canada. . kasey.moss@medportal.ca.
- Department of Medicine, McMaster University, Hamilton, ON, Canada; Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA. brittany.b.dennis@gmail.com.
- Department of Health Research Methods Evidence and Impact, McMaster University, Hamilton, ON, Canada. leen.naji@medportal.ca.
- Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA. aijazahmed@stanford.edu.
- Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA. dhkimmd@stanford.edu.
Zitieren
APA
Moss, K., Dennis, B. B., Naji, L., Ahmed, A., & Kim, D. (2023). Total Bilirubin Levels in Nonalcoholic Fatty Liver Disease and All- cause and Cause-specific Mortality in US Adults. Journal of Gastrointestinal and Liver Diseases, 32(3), 323-331. https://doi.org/10.15403/jgld-4732
Vancouver
Moss K, Dennis BB, Naji L, Ahmed A, Kim D. Total Bilirubin Levels in Nonalcoholic Fatty Liver Disease and All- cause and Cause-specific Mortality in US Adults. Journal of Gastrointestinal and Liver Diseases. 2023;32(3):323-331. doi:10.15403/jgld-4732
BibTeX
@article{Moss2023,
author = {Moss, Kasey and Dennis, Brittany B and Naji, Leen and Ahmed, Aijaz and Kim, Donghee},
title = {Total Bilirubin Levels in Nonalcoholic Fatty Liver Disease and All- cause and Cause-specific Mortality in US Adults},
journal = {Journal of Gastrointestinal and Liver Diseases},
year = {2023},
volume = {32},
number = {3},
pages = {323--331},
doi = {10.15403/jgld-4732}
}
EUVIMED